Veterinary medicine lags decades behind humans. For example, cancers are very common but mostly untreatable in cats. Our own experience with this gap is what motivates us to close it.

Kedi Bioscience is a startup focused on advancing the veterinary application of drug mechanisms that revolutionized care of challenging human diseases.

Our experimental and computational platform discovers novel biologic therapeutics specifically tailored to cats. Kedi’s fully feline drug candidates aim to give veterinarians the treatment arsenal they need to care for life-threatening and chronic diseases.